Extracorporeal shockwave therapy in musculoskeletal disorders

Extracorporeal shockwave therapy in musculoskeletal disorders - Extracorporeal shockwave therapy in musculoskeletal disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026174

Enrollment

Registered

2017-02-17

Start date

2017-02-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

enthesopathy stress fracture non union

Interventions

The extracorporeal shockwave was delivered to the tender area in enthesopathy or the fracture area.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: We follow the adaptation disease that the International Society for Medical Shockwave Treatment make a recommendation.

Exclusion criteria

Exclusion criteria: anticoagulant medication, thrombotic disease, malignant disorder, pregnant woman, The patients who continue receiving cortisone treatment more than six months or the patient who does not pass from the last cortisone injection for six weeks.

Design outcomes

Primary

Measure	Time frame
The change of the pain after the extracorporeal shockwave therapy in enthesopathy, stress fracture and non union.	—

Secondary

Measure	Time frame
The period before making bone union after the extracorporeal shockwave therapy in enthesopathy, stress fracture and non union.	—

Countries

Japan

Contacts

Public ContactTakahiro Igari

Fukushima Medical University School Department of Orthopedic Surgery

igataka@fmu.ac.jp024-547-1276

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026